Literature DB >> 20689942

Clinical and neurocognitive changes with modafinil in obsessive-compulsive disorder: a case report.

Winand H Dittrich, Thomas Johansen, Ashwini K Padhi, Ian E Smith, Samuel R Chamberlain, Naomi A Fineberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20689942     DOI： 10.1007/s00213-010-1958-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  8 in total

1.  D1 dopamine receptors in prefrontal cortex: involvement in working memory.

Authors:  T Sawaguchi; P S Goldman-Rakic
Journal:  Science       Date:  1991-02-22       Impact factor: 47.728

Review 2.  The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers.

Authors:  S R Chamberlain; A D Blackwell; N A Fineberg; T W Robbins; B J Sahakian
Journal:  Neurosci Biobehav Rev       Date:  2005-05       Impact factor: 8.989

Review 3.  Modafinil: a review of neurochemical actions and effects on cognition.

Authors:  Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2007-08-22       Impact factor: 7.853

4.  Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.

Authors:  Pia Weikop; Jan Kehr; Jørgen Scheel-Krüger
Journal:  J Psychopharmacol       Date:  2007-11       Impact factor: 4.153

5.  Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits.

Authors:  M M A Nielen; J A Den Boer
Journal:  Psychol Med       Date:  2003-07       Impact factor: 7.723

6.  Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.

Authors:  Danielle C Turner; Luke Clark; Jonathan Dowson; Trevor W Robbins; Barbara J Sahakian
Journal:  Biol Psychiatry       Date:  2004-05-15       Impact factor: 13.382

Review 7.  Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

Authors:  Mark J Millan
Journal:  Pharmacol Ther       Date:  2006-03-07       Impact factor: 12.310

8.  Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol.

Authors:  Dawn M Eagle; Miles R A Tufft; Hannah L Goodchild; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2007-02-03       Impact factor: 4.415
  8 in total
  2 in total

Review 1.  Management of obsessive-compulsive disorder comorbid with bipolar disorder.

Authors:  Firoz Kazhungil; E Mohandas
Journal:  Indian J Psychiatry       Date:  2016 Jul-Sep       Impact factor: 1.759

2.  Cognitive performance in a subclinical obsessive-compulsive sample 1: cognitive functions.

Authors:  Thomas Johansen; Winand H Dittrich
Journal:  Psychiatry J       Date:  2013-07-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.